VILIN BIO MED LIMITED Share Price

NSE: VILINBIO

S Cap

₹ 44.05

+₹1.30 (3.04%)

Last updated 07 Aug, 2026, 13:04 IST

VILIN BIO MED LIMITED Share Price Today

As of 9 Aug 2026, VILIN BIO MED LIMITED share price is ₹44.05. The stock opened at ₹40.70, compared to its previous close of ₹42.75. During today's trading session, VILIN BIO MED LIMITED share price moved in the range of ₹40.70 to ₹44.05, with an average price of ₹42.38 for the day. Looking at its last 52-week, the stock has touched a low of ₹18.95 and a high of ₹54.40. On the performance front, VILIN BIO MED LIMITED share price has increased by 28.80% over the last six months and is up 55.11% on a year-on-year basis.

₹40.70

3.04% up today

₹44.05

1D LOW

1D HIGH

Stock Performance

OutperformingBeat Nifty by 33.81 % in last 6 month

VILIN BIO MED LIMITED Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹7,76,896+₹2,76,896 (+55.38%)

3 Year

₹9,70,264+₹4,70,264 (+94.05%)

5 Year

₹7,72,807+₹2,72,807 (+54.56%)

₹41.85₹46.25

Circuit Low

Circuit High

₹18.95₹54.40

52-Week Low

52-Week High

Circuit

₹41.85

₹46.25

52-week

₹18.95

₹54.40

About VILIN BIO MED LIMITED

ISIN

INE0L4V01013

Sector Market Cap

₹ 67.18 Cr

Vilin Bio Med Limited is an India-based company engaged in the business of manufacturing and selling pharmaceutical products. The Company is engaged in the manufacturing of pharmaceutical formulations, such as oral liquids, dry syrups, sachets, external preparations, beta and non-beta lactam tablets and capsules and nutritional food supplements. Its products include cardiovascular drugs, musculoskeletal drugs, antibiotic drugs, central nervous system drugs, alimentary system drugs, genitourinary tract drugs, respiratory system and anti-allergic drugs, anti-diabetic drugs, multi-vitamins, minerals and amino acids supplements, miscellaneous drugs, liquid orals and external preparations. Its cardiovascular drugs include ATORVOSTATIN + Aspirin Capsules, Dapagliflozin 10 milligrams (mg) tablets, Fluvastatin Tablets 40 mg, PRASUGREL 10 mg tablets, and Cilnidipine five mg tablets. Its external preparations include calamine lotion, ciprofloxacin, fluocinolone acetonide and others.

VILIN BIO MED LIMITED Financial Highlights

Revenue: VILIN BIO MED LIMITED reported revenue of ₹42.26 crore in FY26 vs ₹15.28 crore in FY25. It showed an increase of 176.57% on a yearly basis.
Operating Profit: VILIN BIO MED LIMITED reported an operating profit of ₹2.84 crore in FY26 vs ₹0.31 crore in FY25. It showed an increase of 816.13% on a year-on-year basis.
Net Profit: VILIN BIO MED LIMITED reported a net profit of ₹1.93 crore in FY26 vs ₹0.22 crore in FY25. It showed an increase of 777.27% on a yearly basis.

Know more

Promoters

56.65%

FII

0.00%

Other DII

0.00%

Retail and other

43.35%

Mutual funds

0.00%

Foreign institutions - FII

FII shareholding by period
Dec 2025	0.00%
Mar 2026	0.00%
May 2026	0.00%
Jun 2026	0.00%

Mkt Cap Cr

67.18

P/E

—

P/B

—

ROE

—

D/E

0.00

ROCE

—

Div. Yield

0.00%

EPS(TTM)

1.37

Turnover

1.48

EV/EBITDA

—

Net Margin

0.00%

Op. Margin

0.00%

ROA

—

Quick Ratio

0.00

Curr. Ratio

0.00

Mkt Cap Cr

67.18

P/E

—

P/B

—

ROE

—

D/E

0.00

ROCE

—

Div. Yield

0.00%

EPS(TTM)

1.37

Turnover

1.48

EV/EBITDA

—

Net Margin

0.00%

Op. Margin

0.00%

ROA

—

Quick Ratio

0.00

Curr. Ratio

0.00

Based on fundamentals, this stock's

Performance

Very Poor

Vilin Bio Med has not beaten FD return of 7%

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,67,630.00	38.59	5.60	13.74%	0.61	17.33%	93.24	0.82%	0.48	10.90
Divis Laboratories	2,18,972.00	74.86	13.06	15.32%	0.00	19.56%	629.49	0.36%	0.55	98.19
Torrent Pharmaceuticals	1,88,358.00	87.37	22.40	25.49%	1.69	13.85%	222.76	0.68%	0.49	58.70
Cipla	1,18,915.00	35.44	3.45	11.27%	0.00	14.95%	423.36	0.88%	0.45	43.52
Zydus Lifesciences	1,11,242.00	17.39	3.23	19.69%	0.35	20.30%	3.70	0.11%	0.39	35.38
Lupin	1,07,907.00	19.44	4.81	23.76%	0.04	24.88%	659.05	0.76%	0.57	129.18
Mankind Pharma	1,00,730.00	48.72	6.18	11.74%	0.34	13.13%	397.02	0.04%	0.44	49.37
Laurus Labs	1,00,228.00	91.92	18.91	16.77%	0.40	16.14%	97.20	0.11%	0.67	13.72
Dr. Reddy's Laboratories	97,824.00	30.73	2.57	11.07%	0.18	12.54%	377.96	0.68%	0.41	38.68
Aurobindo Pharma	96,471.10	26.00	2.55	9.25%	0.19	11.76%	391.14	0.24%	0.38	41.58

VILIN BIO MED LIMITED Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹14.81	₹15.80	₹12.31	₹11.21
Other Income	₹0.47	₹0.32	₹0.02	₹0.00
Total Revenue	₹15.28	₹16.13	₹12.34	₹11.22
Total Expenses	₹14.97	₹15.90	₹10.56	₹11.17
Profit Before Tax	₹0.31	₹0.23	₹1.78	₹0.04
Tax	₹0.08	₹0.06	₹0.54	₹0.01
Profit After Tax	₹0.22	₹0.16	₹1.25	₹0.03
EPS - Basic	₹0.16	₹0.12	₹1.25	₹0.10
EPS - Diluted	₹0.16	₹0.12	₹1.25	₹0.10

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹0.31	₹0.23	₹1.78	₹0.04
Income before WC changes	₹1.26	₹1.14	₹1.95	₹0.26
Change in Assets	₹0.08	-₹4.67	-₹4.17	₹0.11
Change in Liabilities	-₹0.58	-₹3.51	₹1.10	-₹0.15
Change in WC	-₹0.50	-₹8.19	-₹3.07	-₹0.05
Cash flow from Operations	₹0.22	-₹7.42	-₹1.66	₹0.21
Cash flow from Investing	-₹1.11	₹0.32	-₹0.03	₹0.00
Cash flow from Financing	-₹5.10	₹8.87	₹1.68	-₹0.22
Total Cash Flow	-₹5.99	₹1.77	₹0.00	-₹0.01
Cash (Start of the year)	₹6.05	₹0.03	₹0.04	₹0.05
Cash (End of the year)	₹0.06	₹1.81	₹0.03	₹0.04

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹15.17	₹13.79	₹9.62	₹1.65
Current Assets	₹12.56	₹18.62	₹8.05	₹11.91
Total Assets	₹27.73	₹32.40	₹17.68	₹13.56
Current Liabilities	₹4.57	₹9.27	₹6.50	₹5.37
Net Current Asset	₹7.99	₹9.34	₹1.56	₹6.54
Non-Current Liabilities	₹0.09	₹0.29	₹0.50	₹0.79
Equity Capital	₹23.06	₹22.84	₹10.68	₹7.40
Total Equity & Liabilities	₹27.73	₹32.40	₹17.68	₹13.56